Cyclacel Pharmaceuticals, Inc. (CYCC) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 5 Buy, 2 Hold.
The consensus price target is $1.00, representing a downside of 84.3% from the current price $6.37.
CYCC Stock — 12-Month Price Forecast
$1.00
▼ -84.29% Downside
Average Price Target
Based on 7 Wall Street analysts offering 12-month price targets for Cyclacel Pharmaceuticals, Inc., the price target is $1.00.
The average price target represents a -84.29% change from the last price of $6.37.
CYCC Analyst Ratings
Buy
Based on 7 analysts giving stock ratings to Cyclacel Pharmaceuticals, Inc. in the past 3 months
